A kidney’s “worth” depends entirely on who you ask and which side of the transaction you’re on. On the black market, a buyer pays between $50,000 and $200,000 for a kidney. The person who actually gives up the organ typically receives less than 10% of that, often between $1,000 and $10,000. In the legal medical system, a kidney transplant in the United States costs an average of $414,800 when you include all pre- and post-transplant care, but the organ itself has no price tag. Selling organs is illegal in virtually every country on earth.
What a Kidney Costs on the Black Market
Kidneys are the most commonly trafficked organ worldwide. A report from Canada’s Parliament estimates that buyers pay anywhere from $50,000 to $120,000 for a black market kidney, though some cases reach $200,000 depending on the country and urgency. The transaction runs through a sprawling network of brokers, local recruiters, medical professionals, and hospitals willing to perform illicit surgery.
The donor, often called the “vendor” in trafficking research, sees almost none of that money. Individuals from India, Pakistan, Bangladesh, Colombia, and the Philippines have reported receiving between $1,000 and $2,500 for a kidney. Some receive as little as $500, and in documented trafficking cases, some receive nothing at all. Brokers, recruiters, corrupt officials, and collaborating doctors absorb the vast majority of the payment.
This enormous gap between what the buyer pays and what the seller receives is one of the defining features of organ trafficking. It’s not a marketplace in any conventional sense. It’s an exploitation pipeline that preys on people in extreme poverty.
Why Selling a Kidney Is Illegal Almost Everywhere
The international standard is set by the Declaration of Istanbul, a framework endorsed by transplant societies and governments around the world. It defines organ trafficking as the recruitment or transfer of people through threat, force, coercion, fraud, or abuse of vulnerability for the purpose of removing their organs. The declaration specifically targets transplant commercialism, which is the treatment of organs as commodities to be bought and sold.
In the United States, the National Organ Transplant Act of 1984 makes it a federal crime to buy or sell organs, punishable by up to five years in prison and $50,000 in fines. Similar laws exist across Europe, Asia, and most of the rest of the world.
Iran is the one notable exception. The Iranian government provides donors with a payment described as a “gift for altruism,” along with one year of health insurance and coverage of surgical costs. Beyond the government payment, the donor and recipient meet directly, and the donor receives a negotiated additional payment through Patient Kidney Foundations. This system has effectively eliminated Iran’s kidney transplant waiting list, but it remains deeply controversial. Critics point out that donors are overwhelmingly poor, and long-term outcomes for sellers are often worse than for altruistic donors elsewhere.
The Real Cost of a Legal Kidney Transplant
In the legal system, no one pays for the kidney itself. The enormous cost of transplantation covers everything surrounding it: surgical teams, hospital stays, pre-transplant evaluation, organ matching, and extensive follow-up care. According to the National Kidney Registry, the average billed charges for a kidney transplant in the United States come to roughly $414,800. Insurance, Medicare, or Medicaid covers most or all of this for many patients.
The costs don’t stop after surgery. A transplant recipient takes anti-rejection medications for the life of the transplanted kidney. A conservative estimate puts those medications at around $8,000 per year. A transplanted kidney from a living donor typically lasts 15 to 20 years, which means $120,000 to $160,000 in medication costs alone over the organ’s functional life.
What Donors Actually Receive Legally
Living kidney donors in the U.S. don’t receive payment for the organ, but they can get financial help covering the costs that come with donating. The federal government runs the Living Organ Donation Reimbursement Program through HRSA, which provides financial assistance to donors who might not otherwise be able to afford the process. It reimburses qualified expenses including travel, lost wages, child and elder care, and costs related to medical evaluations, surgery, and follow-up visits.
The surgery itself and all associated medical costs are covered by the recipient’s insurance, not the donor’s. Recovery from the procedure typically takes two to six weeks for a laparoscopic surgery.
Long-Term Health Risks for Donors
You can live a normal, healthy life with one kidney. According to Mayo Clinic, the long-term survival rate after kidney donation is about the same as for generally healthy people who never donated. The risk of eventually developing kidney failure after donation exists but is small, less than 1%. That risk is somewhat higher for Black men, though it remains low in absolute terms.
The remaining kidney compensates by growing slightly larger and increasing its filtering capacity. Most donors return to full activity within a month or two and face no lasting restrictions on diet, exercise, or daily life.
Why the Shortage Drives the Market
The illegal kidney trade exists because demand vastly outstrips supply. In 2024, roughly 110,000 kidney transplants were performed worldwide, with 37% coming from living donors. But hundreds of thousands more people remain on waiting lists globally. In the U.S. alone, over 90,000 people are waiting for a kidney at any given time, and the median wait exceeds five years in many regions.
This gap between need and availability creates desperation on both sides. Patients facing years on dialysis, which is physically grueling and carries its own mortality risk, become willing to pay enormous sums. People in severe poverty become willing to undergo surgery for a fraction of what their organ is worth to the buyer. The result is a black market that, by most estimates, accounts for 5% to 10% of transplants performed worldwide each year.
Economists have attempted to calculate what a fair, legal compensation for a kidney might look like if the U.S. were to allow it. Estimates typically land between $15,000 and $40,000 per kidney, based on models that weigh the donor’s risk, recovery time, and the value of the medical benefit to the recipient. Proponents argue this would eliminate the waiting list and undercut the black market. Opponents worry it would create a system where only the poor sell and only the wealthy buy.